Frost & Sullivan Releases the " Report of Assisted Reproductive Technology Industry Status Quo and Development"

Against the backdrop of declining fertility rates and demographic shifts both globally and in China, infertility has gradually become an important public health issue. With continuous advancements in reproductive medicine and the ongoing improvement of fertility-supportive policies, assisted reproductive technology (ART) is increasingly becoming an important medical solution to address fertility challenges. In recent years, China’s assisted reproduction industry has continued to develop, with the number of licensed assisted reproductive medical institutions steadily increasing, overall service capacity improving, and the penetration rate of assisted reproductive technologies among infertile populations gradually rising.
This report analyzes the current development status and future trends of the assisted reproduction industry from both global and Chinese market perspectives. It evaluates the market position and competitive landscape of major industry participants across multiple dimensions, including egg retrieval cycle scale, consumer brand awareness, clinical technology capability, customer service capability, and international operation capability, in order to depict the development dynamics of the assisted reproduction industry in China and globally.